Form 4 for JAZZ Jazz Pharmaceuticals plc
Accepted 2026-03-09 00:00:00 ET · period of report 2026-03-05 · accession 0002013156-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-09 | 2026-03-05 | JAZZ | Johnson Philip L | EVP, CFO | F - Tax | $188.69 | -2,615 | 59.6K | -4% | -$493.4K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-03-05 | F | D | 2,615 | $188.69 | 59,608 | D | — | — |